The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA
Infection and Drug Resistance May 13, 2018
Lai CC, et al. - Researchers aimed at investigating the genotypic differences between different sequence type MRSA isolates, especially focusing on silent rpoB474 mutations and the relationship between such mutations and ciprofloxacin resistance. They identified most occurrences of this rpoB474 silent mutation in community acquired-MRSA (CA-MRSA) isolates with susceptibility to most antibiotics, especially for ciprofloxacin and vice versa. Thus, this mutation might assist in differentiating the different microbiologic characteristics of MRSA clinical isolates.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries